Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige   
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1307 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 Reduced cerebrospinal fluid estradiol levels are associated with early onset and increased β-amyloid levels in Alzheimers disease Schroeder, Johannes
2000
21 S1 p. 61-
1 p.
artikel
1002 Reduced cortical thickness of left inferior parietal region in dementia of the Alzheimer's type Kabani, Noor Jehan
2000
21 S1 p. 106-107
2 p.
artikel
1003 Reduced word repetition effects in the event-related potentials of patients with mild cognitive impairment and incipient Alzheimer's disease Olichney, John M.
2000
21 S1 p. 200-
1 p.
artikel
1004 Reduction of psychotic symptoms in patients with lewy body-like symptoms treated with olanzapine Scott Clark, W.
2000
21 S1 p. 29-
1 p.
artikel
1005 Reduction of the ribosomal RNA in Alzheimer's disease patients Payao, Spencer Marques
2000
21 S1 p. 36-
1 p.
artikel
1006 Regional analysis of abnormal tau protein distribution in progressive supranuclear palsy Zhukareva, Victoria A.
2000
21 S1 p. 17-
1 p.
artikel
1007 Regional brain metabolism predictors of Alzheimer's disease in mild cognitive impairment de Leon, Mony J.
2000
21 S1 p. 132-
1 p.
artikel
1008 Regional brain volumes, cerebrospinal fluid tau and amyloid β peptide in Alzheimer's disease and mild cognitive impairment Blomberg, Mari E.
2000
21 S1 p. 164-
1 p.
artikel
1009 Regional cortical atrophy and cognitive function in an elderly population Berger, Klaus
2000
21 S1 p. 171-
1 p.
artikel
1010 Regional 1H-MR-spectroscopy with respect to the theoretical distribution of neuropathology in AD patients Jessen, Frank
2000
21 S1 p. 178-
1 p.
artikel
1011 Regional patterns of brain N-acetyl aspartate differentiate Alzheimer's disease and vascular dementia Schuff, Norbert
2000
21 S1 p. 202-
1 p.
artikel
1012 Registration of serial magnetic resonance imaging scans in Alzheimer's disease: Sensitivity and specificity of rates of atrophy Jenkins, Rhian
2000
21 S1 p. 39-
1 p.
artikel
1013 Regulation of Aβ-mediated complement activation by vaccinia virus complement control protein Kotwal, Girish Jayant
2000
21 S1 p. 128-
1 p.
artikel
1014 Regulation of β-amyloid induced cytokine and chemokine expression in rat organotypic hippocampal cultures by macrophage colony stimulating factor Vincent, Valerie A.M.
2000
21 S1 p. 49-
1 p.
artikel
1015 Regulation of amyloidogenesis and βAPP trafficking Murayama, Ohoshi
2000
21 S1 p. 50-51
2 p.
artikel
1016 Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures Cedazo-Minguez, Angel
2000
21 S1 p. 252-
1 p.
artikel
1017 Regulation of endogenous amyloid β-protein production by APOE in a human cortical culture model Nadeau, Philip M.
2000
21 S1 p. 41-
1 p.
artikel
1018 Regulation of notch-1 cleavage and signaling by presenilin-1 Song, Weihong
2000
21 S1 p. 67-
1 p.
artikel
1019 Regulation of phosphorylation of tau by protein kinases in rat brain Sengupta, Amitabha
2000
21 S1 p. 150-
1 p.
artikel
1020 Relation of early-life cognitive activity to late-life cognitive function Barnes, Lisa L.
2000
21 S1 p. 244-
1 p.
artikel
1021 Relationship between nitric oxide synthase and choline acetyltransferase in brain in Alzheimer disease Kalisch, Bettina E.
2000
21 S1 p. 84-
1 p.
artikel
1022 Relationship between the serum level of soluble IFN α/βreceptor as an inhibitory factor of IFN and the dementia in the patients with Alzheimer's disease Tateyama, Masaki
2000
21 S1 p. 128-
1 p.
artikel
1023 Relationship of plasma amyloid beta fragments to serum cholesterol HDL, albumin, body mass index and apoe genotype Lerner, Alan J.
2000
21 S1 p. 155-
1 p.
artikel
1024 Relationships between ganglioside GM1 and the transcription of APP gene and the metabolism of APP Zhang, Dai
2000
21 S1 p. 190-
1 p.
artikel
1025 Remission of neuroleptic associated tardive dyskinesia in Alzheimer's disease following treatment with donepezil Sheldon, Leslie J.
2000
21 S1 p. 230-
1 p.
artikel
1026 Repression of presenilin 2 expression by oxidative stress Ghidoni, Roberta
2000
21 S1 p. 52-
1 p.
artikel
1027 Rescue of APP processing in presenilin-1 deficient neurons and fibroblasts: Role of presenilins Wong, Gwendolyn T.
2000
21 S1 p. 181-
1 p.
artikel
1028 Rescue of protein tau-induced axonopathy by GSK-3β in [GSK-3β X HTAU-4R] double transgenic mice Spittaels, Kurt
2000
21 S1 p. 60-
1 p.
artikel
1029 Response to donepezil is not predicted by apolipoprotein E genotype and/or gender Soininen, Hilkka
2000
21 S1 p. 160-161
2 p.
artikel
1030 Results of a recent treatment trial in Alzheimer's disease Mulnard, Ruth A.
2000
21 S1 p. 213-
1 p.
artikel
1031 Retrogenesis in Alzheimer's disease: Functional and cognition relationships Franssen, Emile H.
2000
21 S1 p. 26-
1 p.
artikel
1032 Review of epidemiology and treatment trials in Alzheimer's disease Yaffe, Kristine
2000
21 S1 p. 213-
1 p.
artikel
1033 Risk factor for Alzheimer's disease: The alpha-2-macroglobuline Nicosia, Francesca
2000
21 S1 p. 105-
1 p.
artikel
1034 “Risk factors” and histopathological hallmark lesions of Alzheimer's disease including β-amyloid load in aging and dementia Alafuzoff, Irina I.
2000
21 S1 p. 264-
1 p.
artikel
1035 Risk factors for cognitive decline in healthy older adults Koss, Elisabeth
2000
21 S1 p. 33-
1 p.
artikel
1036 Risk of nursing home placement and mortality in Alzheimer's disease patients without physical impairment Khokhar, Shafiq R.
2000
21 S1 p. 101-
1 p.
artikel
1037 Risk profile for Alzheimer's disease Breteler, Monique M.B.
2000
21 S1 p. 215-
1 p.
artikel
1038 Rivastigmine for dementia with lewy bodies: A case series Collins, Chris C.
2000
21 S1 p. 158-
1 p.
artikel
1039 Rivastigmin treatment effect on the performance of AD patients in a computerized neuropsychological test battery: A preliminary study Fichman, Helenice Charchat
2000
21 S1 p. 240-
1 p.
artikel
1040 Role of anticholinesterase drugs in platelet aggregation. Relationship with Alzheimers disease Iniesta, Juan Antonio
2000
21 S1 p. 238-239
2 p.
artikel
1041 Role of APOE in Alzheimer's disease-like neurodegeneration Holtzman, David M.
2000
21 S1 p. 138-139
2 p.
artikel
1042 Role of elevated amyloid β protein in patients with typical late onset Alzheimer's disease Younkin, Steven G.
2000
21 S1 p. 136-
1 p.
artikel
1043 Role of familial British dementia associated BRI/ABRI peptides in glutamatergic synaptic transmission Parent, Angele T.
2000
21 S1 p. 80-
1 p.
artikel
1044 Role of GPI-anchored proteins in β-secretase processing Sambamurti, Kumar
2000
21 S1 p. 257-
1 p.
artikel
1045 Role of herpes viruses in Alzheimer's disease and of apolipoprotein E in other herpes virus diseases Itzhaki, Ruth F.
2000
21 S1 p. 128-
1 p.
artikel
1046 Role of intracellular cholesterol compartmentation in APP processing and Aβgeneration Puglielli, Luigi
2000
21 S1 p. 206-
1 p.
artikel
1047 Role of nitric oxide in acute cerebral ischemia and the formation of vascular dementia Zhang, Hong
2000
21 S1 p. 10-
1 p.
artikel
1048 Role of presenilin 1 and presenilin 2 in APP and Notch processing De Strooper, Bart
2000
21 S1 p. 76-
1 p.
artikel
1049 Role of presenilin-1 in neuronal differentiation and migration Handler, Melissa
2000
21 S1 p. 24-
1 p.
artikel
1050 Role of protein kinases, protein phosphatases and extracellular signals in the abnormal hyperphosphorylation of tau Grundke-Iqbal, Inge
2000
21 S1 p. 210-
1 p.
artikel
1051 Role of tau in non-familial dementia Wilhelmsen, Kirk C.
2000
21 S1 p. 285-
1 p.
artikel
1052 Role of testicular receptor 2 in the pathogenesis of Alzheimer's disease Weimer, Jill M.
2000
21 S1 p. 182-
1 p.
artikel
1053 Roles of β-amyloid converting enzymes BACE-1 and BACE-2 in β-amyloid secretion Espinoza, Daniel O.
2000
21 S1 p. 254-
1 p.
artikel
1054 Roles of short chain L-3-hydroxyacyl-COA dehydrogenase in the pathogenesis of Alzheimer's disease Yang, Song-Yu
2000
21 S1 p. 149-
1 p.
artikel
1055 Safety and tolerability of high dose aricept-(Donepezil)in patients with Alzheimer's disease Shua-Haim, Joshua R.
2000
21 S1 p. 243-
1 p.
artikel
1056 Safety/efficacy of tetrahydrocannabinol (marinol) in the treatment of Alzheimer's disease patients with refractory agitation Ross, Joel S.
2000
21 S1 p. 238-
1 p.
artikel
1057 Safety of rivastigmine in Alzheimer's disease: Pooled results from phase III studies Potkin, Steven G.
2000
21 S1 p. 170-
1 p.
artikel
1058 Screening for novel Alzheimer's disease genes Pericak-Vance, Margaret A.
2000
21 S1 p. 211-
1 p.
artikel
1059 Search for genetic variability of the phosphoinositide 3-kinase (P13-K) in late onset Alzheimer's disease Liolitsa, Danae
2000
21 S1 p. 175-
1 p.
artikel
1060 γ-Secretase inhibitors which have been shown to block Aβ production do not abolish Notch1 signaling Berezovska, Oksana
2000
21 S1 p. 78-
1 p.
artikel
1061 Seeded growth of amyloid-βfibrils is critical for amyloid-βneurotoxicity: Implications for the pathogenesis of Alzheimer's disease Wright, Sarah
2000
21 S1 p. 259-
1 p.
artikel
1062 Seeding of β-amyloidosis in βAPP-transgenic mice by the intracerebral injection of Alzheimer brain extract Walker, Lary C.
2000
21 S1 p. 126-
1 p.
artikel
1063 Selection bias in studies on alpha2-macroglobulin and APOE frequencies and risk estimation Pirskanen, Mia
2000
21 S1 p. 14-
1 p.
artikel
1064 Selective deafferentation of the rabbit cortex: A new animal model of Alzheimer's disease Roher, Alex E.
2000
21 S1 p. 85-
1 p.
artikel
1065 Selective pathological changes of the periaqueductal gray in Alzheimer's disease Parvizi, Josef
2000
21 S1 p. 122-
1 p.
artikel
1066 Semantic breakdown in early Alzheimer's disease (AD) Schneitter, Marianne
2000
21 S1 p. 159-
1 p.
artikel
1067 Sensitive detection of β-amyloid aggregation by means of time-resolved fluorescence polarisation anisotropy Allsop, David
2000
21 S1 p. 20-21
2 p.
artikel
1068 Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch Haass, Christian
2000
21 S1 p. 141-
1 p.
artikel
1069 Serotonin 5-HT4 receptor binding density is increased in the post mortem neocortex of Alzheimer's disease patients with prominent anxiety Lai, Mitchell K.P.
2000
21 S1 p. 200-201
2 p.
artikel
1070 Seven snapshots of Alzheimer's disease pathology representing preclinical through clinical stages: A grade-of-membership analysis of Huddinge Brain Bank data Corder, Elizabeth H.
2000
21 S1 p. 120-
1 p.
artikel
1071 Sex hormone drugs and behavioral problems in male nursing home residents Ott, Brian R.
2000
21 S1 p. 238-
1 p.
artikel
1072 Sharing the diagnosis in dementia: With whom and with what consequences? Maguire, Conor P.
2000
21 S1 p. 277-
1 p.
artikel
1073 Sharing the diagnosis of dementia: Who wants to know? Wilkinson, Heather A.
2000
21 S1 p. 195-
1 p.
artikel
1074 S100β interactions with tau in alzheimer's disease and the analysis of chemical properties required Fraser, Paul E.
2000
21 S1 p. 221-
1 p.
artikel
1075 Sleep and activity in patients with dementia and their co-residing carers Jones, Roy W.
2000
21 S1 p. 219-
1 p.
artikel
1076 Slow axonal transport of the microtubule-associated protein tau Utton, Michelle A.
2000
21 S1 p. 113-
1 p.
artikel
1077 Sociocultural impact of Alzheimer disease in a group of families. A case study in medical anthropology Suarez, Roberto
2000
21 S1 p. 196-
1 p.
artikel
1078 Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway Paris, Daniel
2000
21 S1 p. 183-
1 p.
artikel
1079 Somal and neuritic accumulation of the Parkinson's disease-associated mutant [A30P]α-synuclein in transgenic mice Kahle, Philipp J.
2000
21 S1 p. 132-
1 p.
artikel
1080 Some characteristics of early and late forms of Alzheimer's disease Danielyan, Konstantin G.
2000
21 S1 p. 235-
1 p.
artikel
1081 Spatial aspects of electrical brain activity in Alzheimer's disease and mild cognitive impairment Huang, Chaorui
2000
21 S1 p. 163-
1 p.
artikel
1082 Specific APP γ-secretase inhibitors do not prevent Notch signalling in vivo Shearman, Mark S.
2000
21 S1 p. 116-
1 p.
artikel
1083 Specific cleavage and nuclear localization of metalloendopeptidase EC3.4.24.15 Slot, Franchot
2000
21 S1 p. 260-
1 p.
artikel
1084 Specific ELISA systems for the detection of endogenous human and rodent ABETA40 and ABETA42 Mercken, Marc
2000
21 S1 p. 41-
1 p.
artikel
1085 Specific intracellular phosphorylation of tau by inducible TPKII (CDK5/P35) activity Sampson, Kathleen E.
2000
21 S1 p. 253-
1 p.
artikel
1086 Specificity of depressive symptoms in Alzheimer's disease Starkstein, Sergio E.
2000
21 S1 p. 28-
1 p.
artikel
1087 Specificity of neuronal loss in the Edinger-Westphal nucleus and its clinical implications Scinto, Leonard F.M.
2000
21 S1 p. 164-
1 p.
artikel
1088 Specific production of Aß peptides from BRI-Aß fusion proteins Lewis, Patrick A.
2000
21 S1 p. 199-
1 p.
artikel
1089 Spect imaging of inflammation in senile dementia of the Alzheimer type: A pilot study Versijpt, Jan
2000
21 S1 p. 252-
1 p.
artikel
1090 Spectrum of ADL impairment and response to rivastigmine varies by severity of alzheimer's disease Messina, John C.
2000
21 S1 p. 222-
1 p.
artikel
1091 Sporadic creutzfeldt-Jakob disease coexistence of biochemically distinct types of PRPSC in the same brain Puoti, Gianfranco
2000
21 S1 p. 149-
1 p.
artikel
1092 Stability of preclinical cognitive deficits in Alzheimer's disease: Evidence from a population-based sample of very-old adults Small, Brent J.
2000
21 S1 p. 200-
1 p.
artikel
1093 Staging of neurofibrillary degeneration in a unique cellular model of the role of human tau filament formation in neurofibrillary degenerative disease Hall, Garth F.
2000
21 S1 p. 20-
1 p.
artikel
1094 Stem cell biology - the search for a cell replacement paradigm Richards, Sarah-Jane
2000
21 S1 p. 185-
1 p.
artikel
1095 Stereological approaches to Alzheimer's disease and age related neuronal loss West, Mark J.
2000
21 S1 p. 72-
1 p.
artikel
1096 Stereologic analysis of vulnerable neocortical neurons in normal aging and Alzheimer's disease Bussiere, Thierry
2000
21 S1 p. 24-25
2 p.
artikel
1097 Strategic of psychoeducative intervention on caregivers of patients with alzheimer's disease Espin Andrade, Ana Margarita
2000
21 S1 p. 240-
1 p.
artikel
1098 Structural domain requirements for presenilin endoproteolysis and Aβ42 overproduction Leem, Jae Yoon
2000
21 S1 p. 261-
1 p.
artikel
1099 Structural maturation of presenilin protein complexes is inhibited by mutation of the conserved intramembrane asparate residues Yu, Gang
2000
21 S1 p. 150-
1 p.
artikel
1100 Structure-function analysis of presenilins Iwatsubo, Takeshi
2000
21 S1 p. 140-
1 p.
artikel
1101 Studies of the amyloid-APoE interaction reveals a common amyloid recognition site on APOE Baumann, Marc H.
2000
21 S1 p. 49-
1 p.
artikel
1102 Studies of the PS-1 pedigree from Columbia Noll, Elizabeth
2000
21 S1 p. 140-141
2 p.
artikel
1103 Subcellular distribution of presenilins, APP and Aβin lymphocytes from a kindred with a new PS1 delta-9 mutation Evin, Genevieve M.
2000
21 S1 p. 159-
1 p.
artikel
1104 Subcortical small vessel dementia Erkinjuntti, Timo
2000
21 S1 p. 7-
1 p.
artikel
1105 Subgroups of Alzheimer disease based on levels of CSF tau, ubiquitin and Aβ1−42 Khatoon, Sabiha
2000
21 S1 p. 31-
1 p.
artikel
1106 Supporting evidence for the existence of a molecular species of presenilin 1 with a seven membrane-spanning and one membrane-embedded structure Nakai, Toshiki
2000
21 S1 p. 46-47
2 p.
artikel
1107 Support program for caregivers of demented patients to adopt to new life situation after institutionalization of the patient Kartano, Maj-Lis E.
2000
21 S1 p. 194-195
2 p.
artikel
1108 Suppression of microglial injury to neurons in Alzheimer's disease Guilian, Dana
2000
21 S1 p. 286-
1 p.
artikel
1109 Surface APP on platelets from patients with Alzheimer's disease is cleaved in the presence of brain endothelial cells and their medium Simons, Elizabeth R.
2000
21 S1 p. 15-
1 p.
artikel
1110 Susceptibility locus for late onset Alzheimer's disease on chromosome 10 Myers, Amanda Jennings
2000
21 S1 p. 103-
1 p.
artikel
1111 Swiss FTDP family with ubiquitin inclusion bodies and without motor neuron disease Kovari, Eniko
2000
21 S1 p. 192-
1 p.
artikel
1112 Synapse loss model in a primary hippocampal co-culture system. Univ Rochester, Rochester, NY 14642 Callahan, Linda M.
2000
21 S1 p. 255-
1 p.
artikel
1113 Synaptic apoptotic and anti-apoptotic signaling in AD and successful brain aging Mattson, M.P.
2000
21 S1 p. 282-283
2 p.
artikel
1114 Synaptosis Cole, Greg Michael
2000
21 S1 p. 282-
1 p.
artikel
1115 Synaptosomes from apolipoprotein E-deficient mice are vulnerable to oxidative insult from Aβ Lauderback, Christopher M.
2000
21 S1 p. 154-
1 p.
artikel
1116 Synuclein and synelfin: The songbird story George, Julia M.
2000
21 S1 p. 283-
1 p.
artikel
1117 α-synuclein lipid binding properties and membrane disruption Jo, Euijung
2000
21 S1 p. 142-
1 p.
artikel
1118 α-Synuclein nitration in neuropathological inclusions Duda, John E.
2000
21 S1 p. 53-
1 p.
artikel
1119 Synucleins: In vitro and in vivo studies Lee, Michael K.
2000
21 S1 p. 284-
1 p.
artikel
1120 Targeted human apoE replacement mice provide a model for studying the role of apoE in Alzheimer's disease Sullivan, Patrick M.
2000
21 S1 p. 18-
1 p.
artikel
1121 Targeting specific behavioral symptoms in Alzheimer's disease using carbamazepine: Results of a pilot, placebo-controlled, randomized, 6-week trial Olin, Jason T.
2000
21 S1 p. 169-
1 p.
artikel
1122 Tau association with aggresomes Nasr, Payman
2000
21 S1 p. 82-
1 p.
artikel
1123 Tau gene analysis in Japanese patients with familial and sporadic frontotemporal dementia Kowalska, Anna
2000
21 S1 p. 147-
1 p.
artikel
1124 Tau gene mutations are pleiotropic: Identification of two novel mutations in the tau gene Stanford, Prudence Mary
2000
21 S1 p. 36-
1 p.
artikel
1125 Tau mutations and gene expression Schellenberg, Gerard D.
2000
21 S1 p. 284-
1 p.
artikel
1126 Tau pathobiology in transgenic mouse models Duff, Karen
2000
21 S1 p. 76-
1 p.
artikel
1127 Tau pathology in families with frontotemporal dementia and Parkinsonism linked to chromosome 17 Spillantini, Maria Grazia
2000
21 S1 p. 285-
1 p.
artikel
1128 Tau phosphorylation and expression in (non)-neuronal cells expressing wild type of mutant (A692G and E693Q) amyloid precursor protein Julliams, Ann
2000
21 S1 p. 113-
1 p.
artikel
1129 Tau phosphorylation regulates cell process formation Biernat, Jacek
2000
21 S1 p. 197-
1 p.
artikel
1130 Tau protein and Alzheimer's disease: Phosphorylation and role in intracellular trafficking Mandelkow, Eva-Maria
2000
21 S1 p. 73-
1 p.
artikel
1131 Tau protein (τ) kinases in the rat heat shock model: Implications for Alzheimer's disease Papasozomenos, Sozos Ch.
2000
21 S1 p. 154-
1 p.
artikel
1132 Tau with three and four microtubule-binding repeats in human brain of Alzheimer's disease and frontotemporal dementia Ingelson, Martin
2000
21 S1 p. 197-
1 p.
artikel
1133 Tea- and bradykinin(BK)-induced calcium responses in Alzheimer's disease (AD) and control fibroblasts: A ratio index with diagnostic capability Etcheberrigaray, Rene
2000
21 S1 p. 12-
1 p.
artikel
1134 Temporal progression of Alzheimer-like neurode-generation in mice expressing anti-nerve growth factor recombinant antibodies Capsoni, Simona
2000
21 S1 p. 19-
1 p.
artikel
1135 Tetracycline-controlled expression of presenilin-1 in transgenic mice Jankowsky, Joanna L.
2000
21 S1 p. 154-
1 p.
artikel
1136 The alpha-2 macroglobulin gene in Alzheimer's disease: A population-based study and meta-analysis Van Duijn, Cornelia M.
2000
21 S1 p. 63-
1 p.
artikel
1137 The Alzheimer disease center's neuropsychological database initiative Grundman, Michael
2000
21 S1 p. 126-127
2 p.
artikel
1138 The amyloid paradox resolved — thioflavine positive abeta deposits lead to local neuropil damage and neuronal death Hyman, Bradley T.
2000
21 S1 p. 72-73
2 p.
artikel
1139 The angiotensin I converting enzyme gene is a susceptibility factor for dementia Amouyel, Philippe
2000
21 S1 p. 103-
1 p.
artikel
1140 The APoE4 allele is associated with enhanced nitric oxide production and enhanced arginine transport Colton, Carol A.
2000
21 S1 p. 254-255
2 p.
artikel
1141 The Arctic APP mutation (E693G) causes Alzheimer's disease through a novel mechanism: Increased amyloid βprotfibril formation and decreased amyloid βlevels in plasma and conditioned media Nilsberth, Camilla
2000
21 S1 p. 58-
1 p.
artikel
1142 The assessment of behavioral disturbances in dementia using a telemetric device Gutzmann, Hans
2000
21 S1 p. 229-
1 p.
artikel
1143 The association between dementia and mid-life risk factors Yamada, Michiko
2000
21 S1 p. 102-
1 p.
artikel
1144 The association between depressive symptoms and cognitive decline in community-dwelling elderly persons Comijs, Hannie C.
2000
21 S1 p. 173-
1 p.
artikel
1145 The association between secondary pathology and functional disability in demented subjects Thomas, Vince S.
2000
21 S1 p. 102-
1 p.
artikel
1146 The association of apolipoprotein E polymorphism and Alzheimer's disease related neuropathological changes is gender- and age-related Ghebremedhin, Estifanos
2000
21 S1 p. 38-
1 p.
artikel
1147 The association of PS1 with the neuronal cytoskeleton and its role in Notch signaling and the regulation of neurite outgrowth Pigino, Gustavo
2000
21 S1 p. 117-
1 p.
artikel
1148 The basel study on the elderly's search for preclinical cognitive markers of Alzheimer's disease Monsch, Andreas Urs
2000
21 S1 p. 31-
1 p.
artikel
1149 The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia Werber, Edith A.
2000
21 S1 p. 234-
1 p.
artikel
1150 The biology and pathology of presenilins Yankner, Bruce A.
2000
21 S1 p. 134-
1 p.
artikel
1151 The CD40-CD40L interaction leads to microglial activation following β-amyloid stimulation Tan, Jun
2000
21 S1 p. 188-
1 p.
artikel
1152 The C. elegans ortholog of the mammalian FE65 family of adaptor proteins retains the ability to interact with Alzheimer's amyloid precursor protein Zambrano, Nicola
2000
21 S1 p. 253-
1 p.
artikel
1153 The cerad neuropsychological assessment battery (Cerad-NAB)—A minimal data set as a common tool for German-speaking Europe Thalmann, Beat
2000
21 S1 p. 30-
1 p.
artikel
1154 The change of 4.1N message expression in Alzheimer's disease brain Sharp, Jessica L.
2000
21 S1 p. 83-
1 p.
artikel
1155 The characteristics of anemia associated with vascular dementia in community dwelling elderly Australians Milward, Elizabeth A.
2000
21 S1 p. 47-
1 p.
artikel
1156 The cholinergic deficit of Alzheimer's disease addressed by transfection of mammalian cell lines Fitzmaurice, Tim J.
2000
21 S1 p. 189-
1 p.
artikel
1157 The class B scavenger receptor CD36 is expressed on microglia and mediates β-amyloid fibrils-induced production of reactive oxygen species El Khoury, Joseph B.
2000
21 S1 p. 255-
1 p.
artikel
1158 The clinical utility of donepezil: From randomized clinical trials to practice Bullock, Roger A.
2000
21 S1 p. 166-
1 p.
artikel
1159 The clock drawing test in Alzheimer's disease and in Lewy body dementia compared with normal elderly subjects Okamoto, Ivan Hideyo
2000
21 S1 p. 233-
1 p.
artikel
1160 The complex relation between blood pressure and dementia Launer, Lenore J.
2000
21 S1 p. 215-
1 p.
artikel
1161 The cut-off score of a Brazilian geriatric population on neuropsychological task Silva, Rosimeire V.
2000
21 S1 p. 95-
1 p.
artikel
1162 The cystatin C gene as a novel genetic risk factor for late onset Alzheimer's disease Crawford, Fiona
2000
21 S1 p. 204-
1 p.
artikel
1163 The deletion polymorphism and VAL1000ILE in α-2-macroglobulin and Alzheimer disease Romas, Stavra N.
2000
21 S1 p. 130-
1 p.
artikel
1164 The development of a human multi-cell culture model of the blood-brain barrier (BBB) for the study of dementia Brennan, Siobhan M.
2000
21 S1 p. 86-
1 p.
artikel
1165 The diagnostic evaluation of dementia in general practice in Denmark Waldorff, Frans Boch
2000
21 S1 p. 32-
1 p.
artikel
1166 The distribution of different heparan sulfate proteoglycans in cerebrovascular amyloid angiopathy of Alzheimer's disease brains van Horssen, Jack
2000
21 S1 p. 191-
1 p.
artikel
1167 The early detection of alzheimer's disease by the benton visual form discrimination test Sato, Mari
2000
21 S1 p. 222-
1 p.
artikel
1168 The economic burden of behavioral and psychological symptoms of dementia (BPSD) in community dwelling patients Schnaider-Beeri, Michal
2000
21 S1 p. 216-
1 p.
artikel
1169 The effect of apolipoprotein E genotypes in Alzheimer's disease: Data from the Canadian study of health and aging Yee, Irene Ml.
2000
21 S1 p. 36-37
2 p.
artikel
1170 The effect of APP overexpression on regulation of amyloidogenesis in myocytes Mazur-Kolecka, Bozena
2000
21 S1 p. 179-
1 p.
artikel
1171 The effect of presenilin on β-amyloid in knock-in mice carrying the human amyloid precursor protein with Swedish and/or London mutation Wiebringhaus, Thomas
2000
21 S1 p. 224-
1 p.
artikel
1172 The effect of sodium azide upon the metabolism of amyloid precursor protein Hedin, Henrietta L.M.
2000
21 S1 p. 108-
1 p.
artikel
1173 The effect of voice of Holley QURAN to decrease aggressive behaviors in people with A.D. Abdollahzadeh, Farahnaz
2000
21 S1 p. 163-
1 p.
artikel
1174 The effects of rivastigmine on behavioral symptoms in severe ad patients in a nursing home setting Anand, Ravi
2000
21 S1 p. 220-221
2 p.
artikel
1175 The evolution of cognitive impairment in the non-demented elderly. Population data from the Kungsholmen project Palmer, Katie Margaret
2000
21 S1 p. 101-
1 p.
artikel
1176 The factor structure of the behavioral rating scale and its relationship to indicators of functional status Thuras, Paul D.
2000
21 S1 p. 195-
1 p.
artikel
1177 The female sex hormone estrogen induces an increased release of soluble non-amyloidogenic amyloid β precursor protein (SAPP) via the activation of mitogen-activated-protein-kinase (MAPKINASE) and phosphokinase C (PKC) Manthey, Dieter
2000
21 S1 p. 114-
1 p.
artikel
1178 The formation of N-terminal truncated Aβ precedes that of full-length Aβ in the human medial temporal lobe Thal, Dietmar R.
2000
21 S1 p. 265-
1 p.
artikel
1179 The genetics of Alzheimer's disease Tanzi, Rudolph E.
2000
21 S1 p. 69-
1 p.
artikel
1180 The genetics of late onset Alzheimer's disease Poduslo, S.E.
2000
21 S1 p. 204-
1 p.
artikel
1181 The Ginkgo biloba extract EGB 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands Yao, Zhi-Xing
2000
21 S1 p. 169-
1 p.
artikel
1182 The home visit: An alternative of care in dementia Ferretti, Ceres Eloah
2000
21 S1 p. 150-
1 p.
artikel
1183 The impact of cerebrovascular disease on Alzheimer pathology in the elderly Kalaria, Raj N.
2000
21 S1 p. 66-67
2 p.
artikel
1184 The importance of mitochondrial damage in Alzheimer's disease varies according to APOE genotype Gibson, Gary E.
2000
21 S1 p. 90-
1 p.
artikel
1185 The incidence of Alzheimer's disease does not vary by gender in Rochester, MN Edland, Steven D.
2000
21 S1 p. 203-
1 p.
artikel
1186 The integrity of carboxyl terminus of presenilin 2 is essential for its functions Tomita, Taisuke
2000
21 S1 p. 110-111
2 p.
artikel
1187 The intron 10 suppressor of tau exon 10 is stemloop-and location-independent D'Souza, Ian
2000
21 S1 p. 196-197
2 p.
artikel
1188 The involvement of arachidonic acid and metabolites in the neurotoxicity of the prion peptide 106–126 Stewart, Leanne R.
2000
21 S1 p. 147-
1 p.
artikel
1189 The length of the transmembrane domain of APP in microsomal membranes is shorter than predicted Beate, Grziwa Katharina
2000
21 S1 p. 261-
1 p.
artikel
1190 The link between accelerated aging and neurofibrillary degeneration in Down syndrome Kuchna, Izabela
2000
21 S1 p. 56-
1 p.
artikel
1191 The longitudinal basis of mild cognitive impairment (MCI) Bullock, Roger A.
2000
21 S1 p. 127-
1 p.
artikel
1192 The mad-B study: A randomized, double-blind, placebo-controlled trial with cerebrolysin in Alzheimer's disease Ruether, Eckhart
2000
21 S1 p. 28-
1 p.
artikel
1193 The meaning of memory loss complaint in a Brazilian geriatric population Minett, Thais S.
2000
21 S1 p. 171-
1 p.
artikel
1194 The neuronal microtubule associated protein tau is a substrate for caspase-3 and an effector of apoptosis Fasulo, Luisa
2000
21 S1 p. 187-
1 p.
artikel
1195 The neuropathology of neurodegeneration with brain iron accumulation, type 1 (NBIA 1) contains insoluble α-synuclean Galvin, James E.
2000
21 S1 p. 65-
1 p.
artikel
1196 The neuropsychological performance of Alzheimer's disease in staging of dementia Wang, Yinghua
2000
21 S1 p. 97-
1 p.
artikel
1197 The next generation of ad therapeutics: The future is now Felsenstein, Kevin M.
2000
21 S1 p. 136-
1 p.
artikel
1198 The next step in notch processing and its relevance to APP biology Kopan, Raphael
2000
21 S1 p. 4-
1 p.
artikel
1199 The Notch transmembrane domain can be cleaved by γ-secretase Zhang, Jimin
2000
21 S1 p. 116-
1 p.
artikel
1200 The Parkin gene in autosomal recessive juvenile Parkinsonism Shimizu, Nobuyoshi
2000
21 S1 p. 135-
1 p.
artikel
1201 The pathology of REM sleep behavior disorder with lewy body dementia: More than co-incidence Scott Turner, R.
2000
21 S1 p. 16-
1 p.
artikel
1202 The pattern of neurodegeneration in the amygdala in dementia with Lewy bodies differs from that found in Alzheimer's disease Kowall, Neil W.
2000
21 S1 p. 54-
1 p.
artikel
1203 The peptidergic antidementia drug cerebrolysin increases neurogenesis in the adult rat dentate gyrus and improves spatial learning and memory Tatebayashi, Yoshitaka
2000
21 S1 p. 42-
1 p.
artikel
1204 The performance of a Brazilian sample in the cognitive subscale of the “Alzheimer's disease assessment scale”- ADAS-COG Schultz, Rodrigo Rizek
2000
21 S1 p. 160-
1 p.
artikel
1205 The physiology and pathophysiology of α-synuclein: A protein chaperone that aggregates Wolozin, Benjamin
2000
21 S1 p. 283-
1 p.
artikel
1206 The P53 inhibitor pifithrin-α protects neurons in experimental models of Alzheimer's disease Culmsee, C.
2000
21 S1 p. 44-
1 p.
artikel
1207 The presenilin gene is very highly conserved throughout evolution Murray, Mark M.
2000
21 S1 p. 48-
1 p.
artikel
1208 The presenilin-interacting protein calsenilin enhances apoptosis and modulates IP3-signaling Lilliehook, Christina
2000
21 S1 p. 256-
1 p.
artikel
1209 The prevalence of dementia in 95-year-olds Borjesson Hanson, Anne M.
2000
21 S1 p. 99-
1 p.
artikel
1210 Therapeutic approaches to prion diseases Tagliavini, Fabrizio
2000
21 S1 p. 209-
1 p.
artikel
1211 The recognition of a small group with exclusive mediotemporal pathology (pick D) within the spectrum of frontotemporal dementia Kamphorst, Wouter
2000
21 S1 p. 55-
1 p.
artikel
1212 The relation of migraine, depression and cognition in cadasil Amberla, Kaarina
2000
21 S1 p. 91-
1 p.
artikel
1213 The relationship between ApoE 4 and lipid metabolism is impaired in Alzheimer's disease Dupuy, Anne-Marie
2000
21 S1 p. 49-
1 p.
artikel
1214 The relationship between motor performance and cognitive function in older Japanese subjects Mimori, Yasuyo
2000
21 S1 p. 35-
1 p.
artikel
1215 The reliability and validity of the Alzheimer's diseases assessment scale cognitive subscale (ADAS-COG) among chinese elderly people in Hong Kong Chu, Leung-wing
2000
21 S1 p. 230-231
2 p.
artikel
1216 The research risk assessment Karlawish, Jason H.
2000
21 S1 p. 6-
1 p.
artikel
1217 The role of alpha-1-antichymotrypsin (ACT) in abeta-amyloidosis of Alzheimer's disease, as studied in novel trigenic PDAPP, mapoe-knockout, GFAP-hACT transgenic mice strains Nilsson, Lars Ng
2000
21 S1 p. 88-
1 p.
artikel
1218 The role of caspase-12 in mediating an ER-specific apoptosis pathway and abeta protein neurototoxicity Yuan, Junying
2000
21 S1 p. 282-
1 p.
artikel
1219 The role of HLA-A2 and TNF-A as putative susceptibility factors in Alzheimer's disease Harris, Judith M.
2000
21 S1 p. 174-175
2 p.
artikel
1220 The role of inflammation in the clinical progression of Alzheimer's disease dementia Pasinetti, Giulio Maria
2000
21 S1 p. 286-
1 p.
artikel
1221 The role of insulin signalling pathway in the regulated secretory processing of the amyloid precursor protein Racchi, Marco
2000
21 S1 p. 109-
1 p.
artikel
1222 The role of mitogen activated protein kinases in complement anaphylatoxin C5A mediated neuroprotection Mukherjee, Piali
2000
21 S1 p. 194-
1 p.
artikel
1223 The role of presenilin and the serca-type Ca2+-ATPase in notch receptor trafficking and proteolysis Fortini, Mark E.
2000
21 S1 p. 25-
1 p.
artikel
1224 The role of presenilin 1 in intercellular adhesion Schwarzman, Alexander L.
2000
21 S1 p. 42-
1 p.
artikel
1225 The role of sphingolipid-cholesterol microdomains (rafts) in processing and transport of the amyloid precursor protein APP Keller, Patrick
2000
21 S1 p. 179-
1 p.
artikel
1226 The role of ¥Á-synuclein (precursor of the non-amyloid ¥âprotein component of Alzheimer's disease) in various neuronal cells Seo, Ji-Heui
2000
21 S1 p. 51-
1 p.
artikel
1227 The role of tau in Alzheimer's disease Ihara, Yasuo
2000
21 S1 p. 210-
1 p.
artikel
1228 The role of T cell reactivity to A-beta amyloid peptide in the pathogenic processes associated with Alzheimer's disease Monsonego, Alon
2000
21 S1 p. 23-
1 p.
artikel
1229 The role of white matter lesions in Alzheimer's disease Skoog, Ingmar
2000
21 S1 p. 215-
1 p.
artikel
1230 The roles of presenilins in APP processing Sisodia, Sangram
2000
21 S1 p. 140-
1 p.
artikel
1231 The stability and endoproteolysis of endogenous presenilin-1 Brunkan, Anne
2000
21 S1 p. 181-
1 p.
artikel
1232 The stereotactical phenomena in traumatic brain injury biomechanics—what long-term consequences? Obreja, Catalin T.
2000
21 S1 p. 148-
1 p.
artikel
1233 The stick design test: A new measure of visuocon-structural ability in subjects with limited education Baiyewu, Olusegun
2000
21 S1 p. 14-
1 p.
artikel
1234 The structural basis of tau filament formation Kuret, Jeff
2000
21 S1 p. 132-133
2 p.
artikel
1235 The structure and function of the amyloid precursor protein N-terminal region Cappai, Roberto
2000
21 S1 p. 46-
1 p.
artikel
1236 The structure of informal care for Alzheimer's disease in Italy Bianchetti, Angelo
2000
21 S1 p. 100-
1 p.
artikel
1237 The syndromic validity of apathy in Alzheimer disease Starkstein, Sergio E.
2000
21 S1 p. 158-
1 p.
artikel
1238 The T cell response to amyloid-beta to mitochondrial antigens in Alzheimer's disease Salvetti, Marco
2000
21 S1 p. 234-
1 p.
artikel
1239 The transition from normal functioning to dementia in the aging population Fratiglioni, Laura
2000
21 S1 p. 280-
1 p.
artikel
1240 The use of drosophila as a model system for studying neurodegeneration Bonini, Nancy M.
2000
21 S1 p. 214-
1 p.
artikel
1241 The utility of medial temporal lobe width in discriminating Alzheimer's disease from normal aging Gao, Fu-qiang
2000
21 S1 p. 97-
1 p.
artikel
1242 The XMNI G-γ−-globin polymorphism interacts with the APOE4 allele and associates with alzheimer's disease Hill, William David
2000
21 S1 p. 206-
1 p.
artikel
1243 Tissue distribution of PRPSC in variant Creutzfeldt-Jakob disease Hill, Andrew F.
2000
21 S1 p. 79-
1 p.
artikel
1244 Tools for evaluation of end-of-life care in dementia Volicer, Ladislav
2000
21 S1 p. 231-
1 p.
artikel
1245 Topographic distribution of PRPRES in Creutzfeldt-Jakob disease as revealed by immunohistochemistry Giaccone, Giorgio
2000
21 S1 p. 54-
1 p.
artikel
1246 Toward identification of gamma-secretase using transition-state analogue inhibitors Esler, William P.
2000
21 S1 p. 278-
1 p.
artikel
1247 Toxic amyloid peptide 25–35 but not the inactive peptide 35-25 reduces neuroprotective properties of metabotropic glutamate (MGLU) receptors Baskys, Andrius
2000
21 S1 p. 189-
1 p.
artikel
1248 Toxicity of a N-terminal fragment of the non-Aß component of Alzheimer's disease amyloid Bodles, Angela M.
2000
21 S1 p. 148-
1 p.
artikel
1249 Toxicity of various amyloid beta peptide species and activated platelets on cultured human blood-brain barrier endothelial cells: Increased toxicity of amyloid dutch type mutant Eisenhauer, Patricia B.
2000
21 S1 p. 220-
1 p.
artikel
1250 “Trait” and “state” aspects of sleep/wake behavior in Alzheimer patients Yesavage, Jerome A.
2000
21 S1 p. 234-
1 p.
artikel
1251 Tramatic brain injury decrease the amount of oligomerized β-amyloid peptide in cerebrospinal fluid Emmerling, Mark R.
2000
21 S1 p. 21-
1 p.
artikel
1252 Transforming growth factor (TGF)-β1 modifies Alzheimer's-type pathology in a transgenic mice and humans Wyss-Coray, Tony
2000
21 S1 p. 125-
1 p.
artikel
1253 Transient ischemic attack predicts time to Alzheimer's disease diagnosis, but other cardiovascular factors do not, the KAME project: A longitudinal study of Japanese Americans in king County, WA Graves, Amy Borenstein
2000
21 S1 p. 33-
1 p.
artikel
1254 Transmission to non-human primates indicates that kuru as well as the ataxic (VV2) or kuruplaque (MV2) variants of sporadic Creutzfeldt-Jakob disease are caused by the same strain of prions Parchi, Piero
2000
21 S1 p. 57-
1 p.
artikel
1255 Treatment of agitation associated with dementia using divalproex sodium Lyketsos, Constantine George
2000
21 S1 p. 230-
1 p.
artikel
1256 Treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial with a neurotrophic agent Panisset, Michel
2000
21 S1 p. 28-
1 p.
artikel
1257 Two novel mutations in the amyloid precursor protein (APP) gene Fernandez-Novoa, Lucia
2000
21 S1 p. 250-
1 p.
artikel
1258 Ubiquitopathies constitute a new class of neuro-degenerative diseases Sonnemans, Marc Af
2000
21 S1 p. 55-
1 p.
artikel
1259 Ultra structure evidence of cell death by necrosis in familial Alzheimer's disease (FAD) PS1-E280A brains Velez-Pardo, Carlos
2000
21 S1 p. 45-
1 p.
artikel
1260 Unbiased detection of atrophy in mild to moderate Alzheimer's disease Rombouts, Serge A.R.B.
2000
21 S1 p. 106-
1 p.
artikel
1261 Unusual Aß amyloid deposition in Alzheimer's disease due to an APP T7141 mutation at the γ42-secretase site De Jonghe, Chris
2000
21 S1 p. 200-
1 p.
artikel
1262 Update of pharmacologic management of behavioral disturbances in Alzheimer's disease Cummings, Jeffrey L.
2000
21 S1 p. 8-
1 p.
artikel
1263 Up-regulation of LDL receptor-related protein expression in Alzheimer's disease and in vitro Qiu, Zhihua
2000
21 S1 p. 192-
1 p.
artikel
1264 Upregulation of presenilin 1 after Aβ1–42 injection in a rat retinal model Bresciani, Laura G.
2000
21 S1 p. 51-
1 p.
artikel
1265 Upregulation of the lysosomal system in experimental models of neuronal injury: Implications for Alzheimer's disease Adamec, Emil
2000
21 S1 p. 181-
1 p.
artikel
1266 Use of an acetylcholinesterase inhibitor in post-CABG encephalopathy—A case study Delaney, John F.
2000
21 S1 p. 239-
1 p.
artikel
1267 Use of the severe impairment battery in a clinical trial of donepezil in moderate to severe Alzheimer's disease Panisset, Michel
2000
21 S1 p. 94-
1 p.
artikel
1268 Utilization of sudan black B in conjunction with Alexa dyes to diminish lipofuscin autofluorescence in human neuronal tissue and controlled mouse tissue O'Herron, Timothy M.
2000
21 S1 p. 145-
1 p.
artikel
1269 Validation of time estimates of the RUD instrument in dementia care Nordberg, Gunilla
2000
21 S1 p. 275-
1 p.
artikel
1270 Variable neuron-specific presenilin 1 transcription increases risk for Alzheimer's disease Theuns, Jessie
2000
21 S1 p. 113-
1 p.
artikel
1271 Variable presentation of Alzheimer's disease and/or spastic paraparesis phenotypes in pedigrees with a novel PS-1 exon 9 gene deletion or exon 9 splice acceptor mutations Kwok, John B.J.
2000
21 S1 p. 25-
1 p.
artikel
1272 Variations of cognitive functions. In hospitaized Alzheimer's disease patients abstract subscription Spiru, L.
2000
21 S1 p. 158-
1 p.
artikel
1273 Vascular abnormalities in APOE4,4 and APOE3,3 Alzheimer's disease Hulette, Christine M.
2000
21 S1 p. 271-
1 p.
artikel
1274 Vascular risk factor and vascular cognitive impairment: What is the relationship? Howard, Kellee A.
2000
21 S1 p. 170-
1 p.
artikel
1275 Vascular risk factors and cognitive aging: The Maastricht aging study Jolles, Jellemer
2000
21 S1 p. 230-
1 p.
artikel
1276 Vascular smooth muscle cell is the primary target of events leading from notch3 mutations to cadasil Joutel, Anne
2000
21 S1 p. 8-
1 p.
artikel
1277 Verbal fluency activates the left medial temporal lobe: A functional magnetic resonance imaging study Pihlajamaki, Maija
2000
21 S1 p. 106-
1 p.
artikel
1278 Vulnerability to neuroleptic side effects in frontotemporal dementia Pijnenburg, Yolande A.L.
2000
21 S1 p. 26-
1 p.
artikel
1279 Web-based screening, data entry and data management in Alzheimer's disease research Andrews, Howard F.
2000
21 S1 p. 160-
1 p.
artikel
1280 Which aspect of episodic memory is most vulnerable in a preclinical phase of Alzheimer's disease? Elfgren, Christina
2000
21 S1 p. 30-
1 p.
artikel
1281 Which caregiver interventions are of benefit: An evidence based approach Brodaty, Henry
2000
21 S1 p. 75-
1 p.
artikel
1282 White matter abnormalities in Alzheimer's disease: Due they reflect vascular disease? Papageorgiou, Sokratis
2000
21 S1 p. 179-
1 p.
artikel
1283 Who is the legal decision-maker with Alzheimer patients? Kapp, Marshall B.
2000
21 S1 p. 6-
1 p.
artikel
1284 Why does dementia need large pragmatic trials? Qizilbash, Nawab
2000
21 S1 p. 25-
1 p.
artikel
1285 Wihdrawn 2000
21 S1 p. 183-
1 p.
artikel
1286 Willingness to participate in an Alzheimer's disease prevention trials among mild cognitively impaired elderly Dominguez-R, Evelyn D.
2000
21 S1 p. 26-
1 p.
artikel
1287 Withdrawn 2000
21 S1 p. 107-
1 p.
artikel
1288 Withdrawn 2000
21 S1 p. 262-
1 p.
artikel
1289 Withdrawn 2000
21 S1 p. 263-
1 p.
artikel
1290 Withdrawn 2000
21 S1 p. 276-
1 p.
artikel
1291 Withdrawn 2000
21 S1 p. 161-
1 p.
artikel
1292 Withdrawn 2000
21 S1 p. 43-
1 p.
artikel
1293 Withdrawn 2000
21 S1 p. 253-
1 p.
artikel
1294 Withdrawn 2000
21 S1 p. 261-
1 p.
artikel
1295 Withdrawn 2000
21 S1 p. 237-
1 p.
artikel
1296 Withdrawn 2000
21 S1 p. 100-
1 p.
artikel
1297 Withdrawn 2000
21 S1 p. 22-
1 p.
artikel
1298 Withdrawn 2000
21 S1 p. 37-
1 p.
artikel
1299 Withdrawn 2000
21 S1 p. 47-
1 p.
artikel
1300 Withdrawn 2000
21 S1 p. 240-
1 p.
artikel
1301 WITHDRAWN 2000
21 S1 p. 126-
1 p.
artikel
1302 Withdrawn 2000
21 S1 p. 223-
1 p.
artikel
1303 Withdrawn 2000
21 S1 p. 240-
1 p.
artikel
1304 Working memory is preserved in Alzheimer's disease but impaired in Parkinson's disease Kensinger, Elizabeth A.
2000
21 S1 p. 230-
1 p.
artikel
1305 X-34 and other congo red-type amyloid binding agents as in vivo amyloid probes Klunk, William E.
2000
21 S1 p. 21-
1 p.
artikel
1306 Young and middle-aged memory clinic patients Elberling, Tina V.
2000
21 S1 p. 144-
1 p.
artikel
1307 Zinc regulates presenilin 1 processing in mouse cortical neuron cultures Park, In-Ho
2000
21 S1 p. 257-
1 p.
artikel
                             1307 gevonden resultaten
 
<< vorige   
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland